Healthcare

Pfizer will request FDA emergency use authorization for COVID-19 vaccine

By Tyler Van Dyke
Published November 20, 2020 12:26pm ET
Add Washington Examiner on Google
Pfizer will request FDA emergency use authorization for COVID-19 vaccine
A lab technician working a bottle containing for COVID-19 vaccine testing at Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand, Monday, May 25, 2020. Thai health officials said that scientists in Thailand have had promising results in testing a COVID-19 vaccine candidate on mice, and have begun testing on monkeys. | (Sakchai Lalit/AP)

Drugmakers Pfizer and BioNTech announced that they will submit their emergency use authorization request to the Food and Drug Administration for their mRNA-based COVID-19 vaccine candidate on Friday.

“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally,” Pfizer Chairman and CEO Dr. Albert Bourla said in a statement. “Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential.”

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 Pfizer Vaccines